Susan G. Hilsenbeck

Researcher Next ID · RN-034032

Researcher · Biochemistry, Genetics and Molecular Biology

Houston, Switzerland

Accepting doctoral researchersFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Estrogen and related hormone effects

Cancer Cells and Metastasis

Cancer-related Molecular Pathways

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
JNCI Journal of the National Cancer Institute · 2019 · https://doi.org/10.1093/jnci/djz042
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Clinical Cancer Research · 2014 · https://doi.org/10.1158/1078-0432.ccr-14-0432
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Proceedings of the National Academy of Sciences · 2009 · https://doi.org/10.1073/pnas.0905718106
Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer
JNCI Journal of the National Cancer Institute · 2003 · https://doi.org/10.1093/jnci/95.5.353
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)14023-8
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
Proceedings of the National Academy of Sciences · 1998 · https://doi.org/10.1073/pnas.95.6.2920

No projects listed.